Literature DB >> 29280047

An evaluation of the protective effect of esomeprazole in an experimental model of renal ischemia-reperfusion.

Tayyar Alp Ozkan1, Nihat Karakoyunlu2, Reyhan Polat3, Gülistan Sanem Sarıbaş4, Nevzat Can Şener5, Seyda Özdemir6, Kevser Peker3, Dilek Ünal3, Can Tuygun2.   

Abstract

PURPOSE: The ischemia and subsequent reperfusion (IR) which occurs in partial nephrectomy used in the treatment of renal tumors causes loss of parenchyma in the damaged kidney. The aim of this study is to evaluate, both biochemically and histologically, the efficacy of esomeprazole in an ischemia-reperfusion model in rat kidneys.
METHODS: The rats were randomized into three groups of seven animals each, referred to as the sham, control, and PPI groups. In the sham group, only a laparotomy was performed. In the control group, following laparotomy the left renal artery was dissected and tied for 30-min ischemia. In the PPI group, a vascular route to the tail vein was opened, and 10 mg/kg esomeprazole was administered. After 1 h, the same procedures described for the control group were performed. All the animals were killed 24 h after the procedure. Biochemical analyses were applied for evaluation of oxidant and antioxidant agents in the blood and left kidney of each subject (oxidative markers: malondialdehyde, myeloperoxidase; antioxidant marker: superoxide dismutase). In the histological examination of the kidney tissues stained with hematoxylin-eosin, the TUNEL method was applied in the evaluation of apoptosis.
RESULTS: No statistically significant biochemical difference was determined in the blood and tissue samples. In the histological and apoptosis evaluations, a statistically significant difference was determined between the sham, control, and PPI groups. The median (IQR) values of the TUNEL-positive cells were counted as 1.50 (4) in the sham group, 11.50 (12) in the control group, and 6.00 (9) in the PPI group (p < 0.001).
CONCLUSIONS: A protective effect of esomeprazole was confirmed in renal ischemia-reperfusion damage created in an experimental rat model.

Entities:  

Keywords:  Esomeprazole; Ischemia–reperfusion injury; Proton pump inhibitors; Rat

Mesh:

Substances:

Year:  2017        PMID: 29280047     DOI: 10.1007/s11255-017-1775-8

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  23 in total

Review 1.  Reperfusion injury.

Authors:  B J Zimmerman; D N Granger
Journal:  Surg Clin North Am       Date:  1992-02       Impact factor: 2.741

Review 2.  The renal H+-K+-ATPases: physiology, regulation, and structure.

Authors:  Michelle L Gumz; I Jeanette Lynch; Megan M Greenlee; Brian D Cain; Charles S Wingo
Journal:  Am J Physiol Renal Physiol       Date:  2009-07-29

3.  Protective effect of tea polyphenols on renal ischemia/reperfusion injury via suppressing the activation of TLR4/NF-κB p65 signal pathway.

Authors:  Yan-Wei Li; Yan Zhang; Ling Zhang; Xu Li; Jian-Bo Yu; Hong-Tao Zhang; Bin-Bin Tan; Lian-Hao Jiang; Ya-Xin Wang; Yu Liang; Xiu-Shan Zhang; Wen-Sheng Wang; Hai-Gen Liu
Journal:  Gene       Date:  2014-03-12       Impact factor: 3.688

4.  Type-2 pericytes participate in normal and tumoral angiogenesis.

Authors:  Alexander Birbrair; Tan Zhang; Zhong-Min Wang; Maria Laura Messi; John D Olson; Akiva Mintz; Osvaldo Delbono
Journal:  Am J Physiol Cell Physiol       Date:  2014-04-30       Impact factor: 4.249

5.  Protective effect of nitric oxide pathway in resveratrol renal ischemia-reperfusion injury in rats.

Authors:  Vikas Chander; Kanwaljit Chopra
Journal:  Arch Med Res       Date:  2006-01       Impact factor: 2.235

6.  Comparison of renal ischemic damage during laparoscopic partial nephrectomy with artery-vein and artery-only clamping.

Authors:  Yasuhito Funahashi; Masashi Kato; Yasushi Yoshino; Takashi Fujita; Naoto Sassa; Momokazu Gotoh
Journal:  J Endourol       Date:  2013-11-19       Impact factor: 2.942

Review 7.  Nocturnal home hemodialysis and short daily hemodialysis compared with kidney transplantation: emerging data in a new era.

Authors:  Robert P Pauly
Journal:  Adv Chronic Kidney Dis       Date:  2009-05       Impact factor: 3.620

8.  Caffeic acid phenethyl ester as a protective agent against doxorubicin nephrotoxicity in rats.

Authors:  Murat Yagmurca; Hasan Erdogan; Mustafa Iraz; Ahmet Songur; Muharrem Ucar; Ersin Fadillioglu
Journal:  Clin Chim Acta       Date:  2004-10       Impact factor: 3.786

Review 9.  Pharmacology of proton pump inhibitors.

Authors:  Jai Moo Shin; George Sachs
Journal:  Curr Gastroenterol Rep       Date:  2008-12

10.  Protective effects of amifostine on ischemia-reperfusion injury of rat kidneys.

Authors:  Ayse Arducoglu Merter; Burhan Mayir; Okan Erdogan; Taner Colak
Journal:  Indian J Pharmacol       Date:  2015 Mar-Apr       Impact factor: 1.200

View more
  2 in total

1.  Drugs Repurposed as Antiferroptosis Agents Suppress Organ Damage, Including AKI, by Functioning as Lipid Peroxyl Radical Scavengers.

Authors:  Eikan Mishima; Emiko Sato; Junya Ito; Ken-Ichi Yamada; Chitose Suzuki; Yoshitsugu Oikawa; Tetsuro Matsuhashi; Koichi Kikuchi; Takafumi Toyohara; Takehiro Suzuki; Sadayoshi Ito; Kiyotaka Nakagawa; Takaaki Abe
Journal:  J Am Soc Nephrol       Date:  2019-11-25       Impact factor: 10.121

2.  Evaluation of pheniramine maleate and zofenopril in reducing renal damage induced by unilateral ureter obstruction. An experimental study.

Authors:  Ercan Yuvanc; Devrim Tuglu; Tunc Ozan; Ucler Kisa; Mahi Balci; Ertan Batislam; Erdal Yilmaz
Journal:  Arch Med Sci       Date:  2019-10-04       Impact factor: 3.318

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.